We are live on
!
Find out more
KCM
Kingstown Capital Management Portfolio holdings
AUM
$30.4M
1-Year Est. Return
3.71%
This Fund
S&P 500
This Quarter
Est. Return
-3.37%
1 Year Est. Return
-3.71%
3 Year Est. Return
+38.62%
5 Year Est. Return
+13.87%
10 Year Est. Return
–
AUM
$60.4M
AUM Growth
-$5.51M
(-8.4%)
Cap. Flow
-$1.45M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
84.15%
Holding
68
New
–
Increased
–
Reduced
3
Closed
5
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paysafe
PSFE
|
+$699K |
| 2 |
PEARW
Pear Therapeutics, Inc. Warrant
PEARW
|
+$158K |
| 3 |
BigBear.ai Holdings Warrant
BBAI.WS
|
+$154K |
| 4 |
RSVRW
Reservoir Media Inc Warrant
RSVRW
|
+$152K |
| 5 |
P3 Health Partners Inc Warrant
PIIIW
|
+$80K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.43% |
| 2 | Industrials | 4.07% |
| 3 | Technology | 2.27% |
| 4 | Consumer Discretionary | 0.16% |
Similar funds
ACM
PGM
VCA
LUGPSI
SAM
SHI
KL
GX
Kingstown Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Kingstown Capital Management held 68 positions worth $60.4M, down 8.4% from $65.9M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Kingstown Capital Management's Q2 2022 filing shows 3 reduced and 5 closed positions. The largest sale was Paysafe, an estimated $699K.
By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 40% a quarter earlier, followed by Industrials and Technology.
- Kingstown Capital Management's biggest Q2 2022 reduction was Paysafe, cutting an estimated $699K.
- Kingstown Capital Management fully exited Pear Therapeutics, Inc. Warrant in Q2 2022, selling an estimated $158K.
- Kingstown Capital Management's ten largest holdings make up 84% of its $60.4M portfolio in Q2 2022.
- Kingstown Capital Management opened 0 new positions and closed 5 in Q2 2022.
- Kingstown Capital Management's portfolio value fell 8.4% quarter-over-quarter to $60.4M.
Based on Kingstown Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.